
Retina
Latest News

Remembering a legend: EURETINA members speak about the Ramin Tadayoni Award
Video Series

CME Content

In this PER On Air Ophthalmology Times podcast, an expert panel discusses the latest advances in X-linked retinitis pigmentosa and how to optimize diagnosis as well as developments in gene therapy.

The future of the tech-forward surgical suite

Australian researchers have found that clinical registries may be an untapped font of information for artificial intelligence.

A meta-analysis indicates a "significant association" between vitamin D deficiency and increased risk of RVO

Clinical associations, imaging strategies and establishing a differential diagnosis from pseudopapilloedema

The product candidate is a modifier gene therapy for broad retinitis pigmentosa indication.

The option is a definitive step forward in the field of vitreoretinal surgery

According to the company, the priority review voucher would be issued upon approval of OPGx-LCA5.

The growing body of evidence that suggests that maintaining adequate levels of vitamin D may be beneficial for preventing and managing RVO.


Stephen R. Russell, MD, discussed the 9-year data he presented at the American Society of Retina Specialists annual meeting for voretigene neparvovec-rzyl.

The Australian Society of Ophthalmologists hosted its inaugural Eye Surgery Showcase, where participants learned how ophthalmologists and the medical technology industry are working together to save the sight of Australians.

Technologies continue to push retina surgical suites into the future

According to the company, the priority review voucher would be issued upon approval of ATSN-201, a gene therapy product candidate.

Researchers noted that patients with sickle cell disease had an increased risk of developing any retinal vascular occlusion.

Lupin has successfully completed a clinical study of LUBT010, a ranibizumab biosimilar to Lucentis

Researchers conducted a retrospective cohort study that included adult patients 18 years and older who underwent primary repair of uncomplicated rhegmatogenous retinal detachment at the Wilmer Eye Institute from January 2008 to December 2018.

Researchers conducted a retrospective cohort study that included adult patients 18 years and older who underwent primary repair of uncomplicated rhegmatogenous retinal detachment at the Wilmer Eye Institute from January 2008 to December 2018.

Researchers from the Shanghai Jiao Tong University School of Medicine developed a deep learning–based model for early identification of myopia, strabismus, and ptosis using 1419 facial photographs from 476 individuals.

Michael Abramoff, MD, PhD, a retina specialist and founder and executive chairman of Digital Diagnostics, points out that much evidence has been collected over the past few decades showing that early detection is key.

A postcard from the American Society of Retina Specialists meeting in Stockholm

The program is for candidate OCU400, a modifier gene therapy product candidate.

The company hosted a virtual KOL event focusing on applicability and real-world experience with suprachoroidal drug delivery, the SCS as a differentiator in the retinal treatment landscape with a focus on wet AMD, and ongoing SCS clinical programs.

According to the company, the wearable smart glasses with both vision enhancement and assistance will be introduced at the American Retina Forum National Meeting

The service expands ophthalmological capabilities and enables providers to deliver the gift of sight to patients with complex retinal conditions in Harlem.





















